SlideShare una empresa de Scribd logo
1 de 31
General pharmacology

               By
 Mohamad-Hesham Daba,MD,PhD
     Associate professor of
     Clinical pharmacology
Intended learning outcomes
• Define pharmacodynamics
• Recognise targets for drug actions
• Classify drug receptors
• Identify agonist, antagonist and partial ag
• Describe graded and quantal dose response
  curves
• Compare bet. affinity, potency and efficacy
• Define therapeutic index
• Discuss the clinical importance of drug
  combination
Drug-body interactions
• Pharmacodynamic
  interactions:
    the effects of the drugs on the body


• Pharmacokinetic interactions:
     the way in which the body handles the
  drugs.
PHARMACODYNAMICS
•   Mechanisms of drug
    action:

•   Body control
    systems:

•   Receptors
•   Ion channels
•   Enzymes
•   Carrier molecules
Receptors
• Definition:
• Receptors are
• protein macromolecules on the surface or
  within the cell
• that combine chemically with small
  molecules (ligands)
• and produces physiological regulatory
  functions.
Membrane receptors
Intracellular receptors
• Ligand: is any molecule that can combine
  with the receptors. A ligand that activates
  the receptor is called agonist. A ligand that
  blocks the receptor is called antagonist.
• Affinity: it is the empathy of the receptor
  to the ligand. It determines the ability of the
  drug to bind to receptors.
• Efficacy: it is the ability of the drug to give
  certain Emax. It means the ability of the drug
  to induce effevt
Agonist means a drug that activates the
receptors upon binding
Pharmacologic antagonist:
means a drug that binds without activating its
 receptors and thereby prevents activation by
 an agonist

Receptor block may be:
Reversible antagonism (Competitive antagonism)
the antagonist effect can be overcome by increasing the
   concentration of agonist

Irreversible antagonism (Non-competitive antagonism)
the antagonist effect cannot be overcome by increasing the
   concentration of agonist
Partial agonistmeans a drug that binds to its receptor but
produces a smaller effect at full dosage than a full agonist
Dose response relationship curves and their
                       importance
•   A. Graded dose-response
•   Importance: 1 Calculation of the ED50        - Potency
                                             - Equieffective doses
                                             - Relative sensitivity
                  2 Calculation of the Emax. - Efficacy (intrinsic activity)
• Calculation of the ED50:
• ED50 is the dose that produces 50% of the maximal response in
  one animal.
• Value of knowing the ED50:
• Comparing the potencies of multiple drugs.
• Comparing the equieffective doses of multiple drugs.


• Calculation of drug efficacy:
• Efficacy is the maximal response (Emax) obtained by a drug.
• Value of knowing the Emax:
• Knowing the maximal responding capacity of the organ.
• Differentiation between full agonists and partial agonists.
• Potency versus efficacy:

• ►Potency: it is the effect of drug in relation to its dose.

• ►Efficacy: it is the ability of the drug to give certain Emax.

• Efficacy is more important than potency because it is the
  major determinant of drug effectiveness while potency has
  little clinical importance because simply you can increase the
  dose of a less potent drug to obtain the effect of a more potent
  one (provided that it is not toxic)
:B. Quantal dose-response curve
•   Importance:
Calculation of the ED50
  (the dose that gives specific
    effect in 50% of treated
    group of animals)
Calculation of the LD50
  (the dose that kills 50% of
    treated animals)
Determination of the therapeutic
    index
    T.I.=LD50/ ED50
    (it must be >1)
• The therapeutic index (also
  known as therapeutic ratio) is
  a comparison of the amount of a
  therapeutic agent that causes the
  therapeutic effect to the amount
  that causes death (in animal
  studies) or toxicity (in human
  studies).


  So, in humans
  therapeutic index or ratio
  =TD50/ ED50
Quick quiz
1.Which branch of pharmacology studies the
   way drugs work in living organism?

C.   Pharmacotherapeutics
D.   Pharmacokinitics
E.   Pharmacogenitics
F.   Pharmacodynamics
G.   Pharmacovigilance
Quick quiz
•     A 55-year-old woman with congestive heart failure is to
      be treated with a diuretic drug. Drugs X and Y have the
      same mechanism of diuretic action. Drug X in a dose of
      5mg produces the same magnitude of diuresis as 500 mg
      of drug Y. This suggests that:
A.    Drug Y is less efficacious than drug X.
B.   Drug X is about 100 times more potent than drug Y.
C.   Toxicity of drug X is less than that of drug Y.
D.    Drug X is a safer drug than drug Y.
E.   Drug X will have a shorter duration of action than drug Y
      because less of drug X is present for a given effect.
Quick quiz
1.   In the absence of other drug, pindolol causes an increase
     in heart rate by activating beta adrenoceptors. In the
     presence of highly effective beta stimulants, however,
     pindolol causes a dose-dependent, reversible decrease in
     heart rate. Therefore pindolol is probably:
A.   An irreversible antagonist.
B.   A physiologic antagonist.
C.   A chemical antagonist.
D.   A partial agonist.
E.   A Spare receptor agonist.
Quick quiz
1. Which of the following provides
   information about the variation in
   sensitivity to the drug within the
   population studied?
A. Maximal efficacy.
B. Therapeutic index.
C. Drug potency.
D. Graded dose-response curve.
E. Quantal dose-response curve.
Quick quiz
5. Which of the following provides
    information about the largest response a
    drug can produces, regardless of dose?
.A. Drug potency
.B. Maximal efficacy
.C. Mechanism of receptor action
.D. Therapeutic index
.E. Therapeutic window
HYPOREACTIVITY TO
             DRUGS
• Tolerance: decreased response to the same dose of
  the drug. The same response could be obtained by
  higher doses. It occurs over a long period
• Tachyphylaxis: it is a type of tolerance, which occurs
  very rapidly.

Probable mechanisms:
• Change in receptors (desensitization):
• Loss of receptors (down-regulation):
•   Exhaustion of mediators:
•   Increased metabolic degradation:
•   Physiological adaptation:
HYPERREACTIVITY TO DRUGS
overshoot phenomena or hypersusceptibility or
intolerance

Up-regulation means increase number of receptors
due to prolonged exposure to the antagonist or
prolonged deficiency of the natural agonist. When the
antagonist is suddenly withdrawn, severe reaction
occurs in the form of rebound or withdrawal effects
e.g. severe tachycardia & arrhythmia can occur after
sudden stoppage of beta-blockers.
DRUG COMBINATION
• Summation and addition: combined effects of two drugs are
  equal to the sum of their individual effects.
• Synergism or potentiation: combined effects of drugs may be
  greater than the sum of their individual effects.
• Antagonism:
            - Chemical antagonism:
            - Physical antagonism:
            - Physiological antagonism:
            - Competitive antagonism:
            - Non-competitive antagonism
• Which of the following terms best
  describes the antagonism of leukotriene’s
  bronchoconstrictor effect (mediated at
  leukotriene receptors) by terbutaline
  (acting at adrenoceptors) in a patient with
  asthma?
2.   Pharmacologic antagonist.
3.   Partial agonist.
4.   Physiologic antagonist.
5.   Chemical antagonist.
6.   Noncompetitive antagonist.
• Many drugs produce effects by
  interaction with receptors. Other
  cellular components with which drugs
  interact to produce effects include:
2.   Nucleic acids.
3.   Structural proteins.
4.   Enzymes.
5.   Proteins involved in transport processes.
6.   All of the above.
• Which of the following chemical
  compounds produce their major
  effects by binding to intracellular
  receptors that bind to nuclear DNA?
2.   Insulin.
3.   Succinylcholine.
4.   Catecholamines.
5.   Opioid peptides.
6.   Steroids.
The term that refers to the rapid
 diminution of responsiveness
 following administration of a drug
 is:
2.hyporeactivity
3.idiosyncratic drug response
4.tolerance
5.drug inactivation
6.tachyphylaxis
MATCH the pharmacologic term in the answers below with the most
            :appropriate definition of the term in the items


•    Efficacy
•    Potency
•    Tolerance
•    Therapeutic index
•    Intolerance



A) Decreased response to the same dose of the drug.
B) When the antagonist is suddenly withdrawn, severe reaction occurs in the
    form of rebound or withdrawal effects
C) This is the maximal response obtainable by a drug treatment
D) This is the ratio of the toxic dose to the therapeutic dose
E) This is the amount of drug required to produce a desired effect

Más contenido relacionado

La actualidad más candente

Receptor Pharmacology
Receptor PharmacologyReceptor Pharmacology
Receptor Pharmacology
Tulasi Raman
 

La actualidad más candente (20)

Pharmacodynamics (Mechanisn of drug action)
Pharmacodynamics (Mechanisn of drug action) Pharmacodynamics (Mechanisn of drug action)
Pharmacodynamics (Mechanisn of drug action)
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Efficacy and Potency of drug
Efficacy and Potency of drugEfficacy and Potency of drug
Efficacy and Potency of drug
 
Antifungal drugs
Antifungal drugs Antifungal drugs
Antifungal drugs
 
Biotransformation-pharmacology
Biotransformation-pharmacologyBiotransformation-pharmacology
Biotransformation-pharmacology
 
Classification of antimicrobial drugs
Classification of antimicrobial drugsClassification of antimicrobial drugs
Classification of antimicrobial drugs
 
Receptor - Pharmacology
Receptor - PharmacologyReceptor - Pharmacology
Receptor - Pharmacology
 
2.Mechanism of drug actons
2.Mechanism of drug actons2.Mechanism of drug actons
2.Mechanism of drug actons
 
Dr.Lavanya - Factors modifying drug effect
Dr.Lavanya - Factors modifying drug effectDr.Lavanya - Factors modifying drug effect
Dr.Lavanya - Factors modifying drug effect
 
Adverse drug reaction
Adverse   drug  reactionAdverse   drug  reaction
Adverse drug reaction
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
First pass metabolism- Buddhabhushan dongre
First pass metabolism- Buddhabhushan dongreFirst pass metabolism- Buddhabhushan dongre
First pass metabolism- Buddhabhushan dongre
 
5ee1 adverse drug reaction
5ee1 adverse drug reaction5ee1 adverse drug reaction
5ee1 adverse drug reaction
 
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...
 
Pharmacology of diabetes mellitus
Pharmacology of diabetes mellitusPharmacology of diabetes mellitus
Pharmacology of diabetes mellitus
 
Drugs used in treatment of rheumatoid arthiritis
Drugs used in treatment of rheumatoid arthiritisDrugs used in treatment of rheumatoid arthiritis
Drugs used in treatment of rheumatoid arthiritis
 
Pharmacokinetics: Excretion of drugs
Pharmacokinetics: Excretion of drugsPharmacokinetics: Excretion of drugs
Pharmacokinetics: Excretion of drugs
 
Receptor Pharmacology
Receptor PharmacologyReceptor Pharmacology
Receptor Pharmacology
 
Paediatric drugs, its dose and dosage forms
Paediatric drugs, its dose and dosage formsPaediatric drugs, its dose and dosage forms
Paediatric drugs, its dose and dosage forms
 

Similar a Pharmacodynamics revised

pharmacodynamics 1.pdf
pharmacodynamics 1.pdfpharmacodynamics 1.pdf
pharmacodynamics 1.pdf
Imtiyaz60
 
pharmacodynamics 1.pptx
pharmacodynamics 1.pptxpharmacodynamics 1.pptx
pharmacodynamics 1.pptx
Imtiyaz60
 
2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt
2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt
2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt
wakogeleta
 

Similar a Pharmacodynamics revised (20)

Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Parmacodynamics.pptx
Parmacodynamics.pptxParmacodynamics.pptx
Parmacodynamics.pptx
 
Pharmacodynamics.pptx
Pharmacodynamics.pptxPharmacodynamics.pptx
Pharmacodynamics.pptx
 
Pharmacodynamics, mechanism of drug action
Pharmacodynamics, mechanism of drug actionPharmacodynamics, mechanism of drug action
Pharmacodynamics, mechanism of drug action
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Pharmacodynamics.ppt
Pharmacodynamics.pptPharmacodynamics.ppt
Pharmacodynamics.ppt
 
pharmacodynamics 1.pdf
pharmacodynamics 1.pdfpharmacodynamics 1.pdf
pharmacodynamics 1.pdf
 
Pharmacodynamics PPT
Pharmacodynamics PPTPharmacodynamics PPT
Pharmacodynamics PPT
 
Pharmacodynamics
Pharmacodynamics Pharmacodynamics
Pharmacodynamics
 
Pharmacology pdf
Pharmacology pdfPharmacology pdf
Pharmacology pdf
 
pharmacodynamics 1.pptx
pharmacodynamics 1.pptxpharmacodynamics 1.pptx
pharmacodynamics 1.pptx
 
branch of pharmacology dedicated to determine the fate of substances administ...
branch of pharmacology dedicated to determine the fate of substances administ...branch of pharmacology dedicated to determine the fate of substances administ...
branch of pharmacology dedicated to determine the fate of substances administ...
 
Pharmacodynamics.2020
Pharmacodynamics.2020Pharmacodynamics.2020
Pharmacodynamics.2020
 
Pharmacodynamics 2020
Pharmacodynamics 2020 Pharmacodynamics 2020
Pharmacodynamics 2020
 
Dental Pharmacology- Pharmacodynamic
Dental Pharmacology- PharmacodynamicDental Pharmacology- Pharmacodynamic
Dental Pharmacology- Pharmacodynamic
 
2022_UMSU PHARMACODYNAMIC 1 2.pptx
2022_UMSU PHARMACODYNAMIC 1  2.pptx2022_UMSU PHARMACODYNAMIC 1  2.pptx
2022_UMSU PHARMACODYNAMIC 1 2.pptx
 
Pharma 2012 introduction lec 1 final 2012
Pharma 2012 introduction lec 1 final 2012Pharma 2012 introduction lec 1 final 2012
Pharma 2012 introduction lec 1 final 2012
 
2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt
2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt
2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt
 
Pharmacodynamics
Pharmacodynamics Pharmacodynamics
Pharmacodynamics
 
Chapter02
Chapter02Chapter02
Chapter02
 

Más de Omar Moatamed

Physiology of Menopause
Physiology of MenopausePhysiology of Menopause
Physiology of Menopause
Omar Moatamed
 
Vessels & nerves of lower limb
Vessels & nerves of lower limbVessels & nerves of lower limb
Vessels & nerves of lower limb
Omar Moatamed
 
Histology of the breast
Histology of the breastHistology of the breast
Histology of the breast
Omar Moatamed
 
Tolerance & autoimmunity
Tolerance & autoimmunityTolerance & autoimmunity
Tolerance & autoimmunity
Omar Moatamed
 
Psychological impact of chronic illness2
Psychological impact of chronic illness2Psychological impact of chronic illness2
Psychological impact of chronic illness2
Omar Moatamed
 
The back of the thigh and popliteal fossa
The back of the thigh and popliteal fossaThe back of the thigh and popliteal fossa
The back of the thigh and popliteal fossa
Omar Moatamed
 
Phobia & its Treatment
Phobia & its TreatmentPhobia & its Treatment
Phobia & its Treatment
Omar Moatamed
 
Organization of the ll, front and medial sides of thigh
Organization of the ll, front and medial sides of thighOrganization of the ll, front and medial sides of thigh
Organization of the ll, front and medial sides of thigh
Omar Moatamed
 
Histology (Skin) - Part 2
Histology (Skin) - Part 2Histology (Skin) - Part 2
Histology (Skin) - Part 2
Omar Moatamed
 

Más de Omar Moatamed (20)

Physiology of Menopause
Physiology of MenopausePhysiology of Menopause
Physiology of Menopause
 
Vessels & nerves of lower limb
Vessels & nerves of lower limbVessels & nerves of lower limb
Vessels & nerves of lower limb
 
Histology of the breast
Histology of the breastHistology of the breast
Histology of the breast
 
Anti cancer drugs
Anti cancer drugsAnti cancer drugs
Anti cancer drugs
 
Pharmacogenetics
PharmacogeneticsPharmacogenetics
Pharmacogenetics
 
Anti cancer drugs
Anti cancer drugsAnti cancer drugs
Anti cancer drugs
 
Staging of cancer
Staging of  cancerStaging of  cancer
Staging of cancer
 
Anatomy of the Leg
Anatomy of the LegAnatomy of the Leg
Anatomy of the Leg
 
General Mycology
General MycologyGeneral Mycology
General Mycology
 
Tolerance & autoimmunity
Tolerance & autoimmunityTolerance & autoimmunity
Tolerance & autoimmunity
 
Psychological impact of chronic illness2
Psychological impact of chronic illness2Psychological impact of chronic illness2
Psychological impact of chronic illness2
 
The back of the thigh and popliteal fossa
The back of the thigh and popliteal fossaThe back of the thigh and popliteal fossa
The back of the thigh and popliteal fossa
 
Gluteal region
Gluteal regionGluteal region
Gluteal region
 
Gulteal region
Gulteal regionGulteal region
Gulteal region
 
Bacterial Virulence
Bacterial VirulenceBacterial Virulence
Bacterial Virulence
 
SLE
SLESLE
SLE
 
Hypersensitivity
HypersensitivityHypersensitivity
Hypersensitivity
 
Phobia & its Treatment
Phobia & its TreatmentPhobia & its Treatment
Phobia & its Treatment
 
Organization of the ll, front and medial sides of thigh
Organization of the ll, front and medial sides of thighOrganization of the ll, front and medial sides of thigh
Organization of the ll, front and medial sides of thigh
 
Histology (Skin) - Part 2
Histology (Skin) - Part 2Histology (Skin) - Part 2
Histology (Skin) - Part 2
 

Último

1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 

Último (20)

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 

Pharmacodynamics revised

  • 1. General pharmacology By Mohamad-Hesham Daba,MD,PhD Associate professor of Clinical pharmacology
  • 2. Intended learning outcomes • Define pharmacodynamics • Recognise targets for drug actions • Classify drug receptors • Identify agonist, antagonist and partial ag • Describe graded and quantal dose response curves • Compare bet. affinity, potency and efficacy • Define therapeutic index • Discuss the clinical importance of drug combination
  • 3. Drug-body interactions • Pharmacodynamic interactions: the effects of the drugs on the body • Pharmacokinetic interactions: the way in which the body handles the drugs.
  • 4. PHARMACODYNAMICS • Mechanisms of drug action: • Body control systems: • Receptors • Ion channels • Enzymes • Carrier molecules
  • 5. Receptors • Definition: • Receptors are • protein macromolecules on the surface or within the cell • that combine chemically with small molecules (ligands) • and produces physiological regulatory functions.
  • 7.
  • 9. • Ligand: is any molecule that can combine with the receptors. A ligand that activates the receptor is called agonist. A ligand that blocks the receptor is called antagonist. • Affinity: it is the empathy of the receptor to the ligand. It determines the ability of the drug to bind to receptors. • Efficacy: it is the ability of the drug to give certain Emax. It means the ability of the drug to induce effevt
  • 10. Agonist means a drug that activates the receptors upon binding
  • 11.
  • 12. Pharmacologic antagonist: means a drug that binds without activating its receptors and thereby prevents activation by an agonist Receptor block may be: Reversible antagonism (Competitive antagonism) the antagonist effect can be overcome by increasing the concentration of agonist Irreversible antagonism (Non-competitive antagonism) the antagonist effect cannot be overcome by increasing the concentration of agonist
  • 13. Partial agonistmeans a drug that binds to its receptor but produces a smaller effect at full dosage than a full agonist
  • 14. Dose response relationship curves and their importance • A. Graded dose-response • Importance: 1 Calculation of the ED50 - Potency - Equieffective doses - Relative sensitivity 2 Calculation of the Emax. - Efficacy (intrinsic activity)
  • 15. • Calculation of the ED50: • ED50 is the dose that produces 50% of the maximal response in one animal. • Value of knowing the ED50: • Comparing the potencies of multiple drugs. • Comparing the equieffective doses of multiple drugs. • Calculation of drug efficacy: • Efficacy is the maximal response (Emax) obtained by a drug. • Value of knowing the Emax: • Knowing the maximal responding capacity of the organ. • Differentiation between full agonists and partial agonists.
  • 16. • Potency versus efficacy: • ►Potency: it is the effect of drug in relation to its dose. • ►Efficacy: it is the ability of the drug to give certain Emax. • Efficacy is more important than potency because it is the major determinant of drug effectiveness while potency has little clinical importance because simply you can increase the dose of a less potent drug to obtain the effect of a more potent one (provided that it is not toxic)
  • 17. :B. Quantal dose-response curve • Importance: Calculation of the ED50 (the dose that gives specific effect in 50% of treated group of animals) Calculation of the LD50 (the dose that kills 50% of treated animals) Determination of the therapeutic index T.I.=LD50/ ED50 (it must be >1)
  • 18. • The therapeutic index (also known as therapeutic ratio) is a comparison of the amount of a therapeutic agent that causes the therapeutic effect to the amount that causes death (in animal studies) or toxicity (in human studies). So, in humans therapeutic index or ratio =TD50/ ED50
  • 19. Quick quiz 1.Which branch of pharmacology studies the way drugs work in living organism? C. Pharmacotherapeutics D. Pharmacokinitics E. Pharmacogenitics F. Pharmacodynamics G. Pharmacovigilance
  • 20. Quick quiz • A 55-year-old woman with congestive heart failure is to be treated with a diuretic drug. Drugs X and Y have the same mechanism of diuretic action. Drug X in a dose of 5mg produces the same magnitude of diuresis as 500 mg of drug Y. This suggests that: A. Drug Y is less efficacious than drug X. B. Drug X is about 100 times more potent than drug Y. C. Toxicity of drug X is less than that of drug Y. D. Drug X is a safer drug than drug Y. E. Drug X will have a shorter duration of action than drug Y because less of drug X is present for a given effect.
  • 21. Quick quiz 1. In the absence of other drug, pindolol causes an increase in heart rate by activating beta adrenoceptors. In the presence of highly effective beta stimulants, however, pindolol causes a dose-dependent, reversible decrease in heart rate. Therefore pindolol is probably: A. An irreversible antagonist. B. A physiologic antagonist. C. A chemical antagonist. D. A partial agonist. E. A Spare receptor agonist.
  • 22. Quick quiz 1. Which of the following provides information about the variation in sensitivity to the drug within the population studied? A. Maximal efficacy. B. Therapeutic index. C. Drug potency. D. Graded dose-response curve. E. Quantal dose-response curve.
  • 23. Quick quiz 5. Which of the following provides information about the largest response a drug can produces, regardless of dose? .A. Drug potency .B. Maximal efficacy .C. Mechanism of receptor action .D. Therapeutic index .E. Therapeutic window
  • 24. HYPOREACTIVITY TO DRUGS • Tolerance: decreased response to the same dose of the drug. The same response could be obtained by higher doses. It occurs over a long period • Tachyphylaxis: it is a type of tolerance, which occurs very rapidly. Probable mechanisms: • Change in receptors (desensitization): • Loss of receptors (down-regulation): • Exhaustion of mediators: • Increased metabolic degradation: • Physiological adaptation:
  • 25. HYPERREACTIVITY TO DRUGS overshoot phenomena or hypersusceptibility or intolerance Up-regulation means increase number of receptors due to prolonged exposure to the antagonist or prolonged deficiency of the natural agonist. When the antagonist is suddenly withdrawn, severe reaction occurs in the form of rebound or withdrawal effects e.g. severe tachycardia & arrhythmia can occur after sudden stoppage of beta-blockers.
  • 26. DRUG COMBINATION • Summation and addition: combined effects of two drugs are equal to the sum of their individual effects. • Synergism or potentiation: combined effects of drugs may be greater than the sum of their individual effects. • Antagonism: - Chemical antagonism: - Physical antagonism: - Physiological antagonism: - Competitive antagonism: - Non-competitive antagonism
  • 27. • Which of the following terms best describes the antagonism of leukotriene’s bronchoconstrictor effect (mediated at leukotriene receptors) by terbutaline (acting at adrenoceptors) in a patient with asthma? 2. Pharmacologic antagonist. 3. Partial agonist. 4. Physiologic antagonist. 5. Chemical antagonist. 6. Noncompetitive antagonist.
  • 28. • Many drugs produce effects by interaction with receptors. Other cellular components with which drugs interact to produce effects include: 2. Nucleic acids. 3. Structural proteins. 4. Enzymes. 5. Proteins involved in transport processes. 6. All of the above.
  • 29. • Which of the following chemical compounds produce their major effects by binding to intracellular receptors that bind to nuclear DNA? 2. Insulin. 3. Succinylcholine. 4. Catecholamines. 5. Opioid peptides. 6. Steroids.
  • 30. The term that refers to the rapid diminution of responsiveness following administration of a drug is: 2.hyporeactivity 3.idiosyncratic drug response 4.tolerance 5.drug inactivation 6.tachyphylaxis
  • 31. MATCH the pharmacologic term in the answers below with the most :appropriate definition of the term in the items • Efficacy • Potency • Tolerance • Therapeutic index • Intolerance A) Decreased response to the same dose of the drug. B) When the antagonist is suddenly withdrawn, severe reaction occurs in the form of rebound or withdrawal effects C) This is the maximal response obtainable by a drug treatment D) This is the ratio of the toxic dose to the therapeutic dose E) This is the amount of drug required to produce a desired effect